Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Citi - 2025 Medtech & Life Sciences Access Day on Thursday, February 27, 2025. Joel Grade, Baxter's chief financial ...

Baxter International Inc. BAX is scheduled to release fourth-quarter 2024 results on Feb. 13, before the opening bell. In the ...

Baxter International Inc. (NYSE:BAX – Get Free Report) has been assigned an average recommendation of “Hold” from the ten brokerages that are covering the stock, MarketBeat.com reports. One equities ...

Baxter International Inc. closed 29.99% short of its 52-week high of $44.01, which the company reached on March 8th.

Investors don't like tariffs. The S&P 500 was down 1.9% in morning trading Monday, and 91% of its component stocks were down, after President Donald Trump announced 25% tariffs on imports from Mexico ...

Brent Shafer, who was appointed as Baxter’s Chair and Interim CEO in February 2025, has served as the Chairman and CEO of ...

Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...

Baxter International BAX announced longtime CEO Joe Almeida would be retiring immediately, without a successor in place, ...

Baxter International Inc. (BAX), a healthcare company, Monday announced the appointment of Lead Independent Director Brent Shafer as ...

Baxter International Inc. (NYSE:BAX), a global leader in medical technology, announced today the immediate retirement of José ...